Lauren Tidwell, PA
Medical · Huntsville, ALNPI 1497204002
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 522 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,833, 4.6 times the $613 reported in 2021. Among medical clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 522 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$1K
- UCB, Inc.$722
- Acadia Pharmaceuticals Inc$469
- AstraZeneca$468
- Pfizer$422
- plus $3K from 35 others
What the payments were for
- Speaking & faculty fees$160%
- Food & beverage$8,213100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,230 in reported general payments places this provider in the 90th percentile of 175 medical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 150 | $5,433 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 58 | $2,358 |
| Levetiracetam | 41 | $1,976 |
| Donepezil Hcl | 135 | $1,533 |
| Divalproex Sodium | 30 | $759 |
| Primidone | 29 | $505 |
| Duloxetine Hcl | 15 | $374 |
| Citalopram HbrCitalopram Hydrobromide | 20 | $312 |
| Ropinirole Hcl | 12 | $208 |
| Quetiapine Fumarate | 21 | $171 |
| Escitalopram Oxalate | 14 | $117 |
Paid to pharmacies, not to this prescriber.
Other medical in Huntsville
- Reiga EvansHuntsville$8K
- Tiffany WimsattHuntsville$7K
- Lanita ReidHuntsville$4K
- Lindsey MangumFlorence$44K
- Jaime DunnBirmingham$16K
- Stacy RichersonMobile$12K
- Susannah CashAuburn$11K
- Deana PorterAuburn$9K
- Rachel ThompsonFairhope$9K
- Shelley WinzelerHomewood$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.